Brief: Aurobindo Pharma USA Receives FTC Approval To Acquire Lannett Company
Yesterday 03:04
BRIEF-Aurobindo Pharma USA Receives FTC Approval To Acquire Lannett Company June 22 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA - AUROBINDO PHARMA USA RECEIVES FTC APPROVAL TO ACQUIRE LANNETT COMPANY
AUROBINDO PHARMA - DEAL VALUED AT $250 MILLION
Source text: ID:nnAZN4T3F3C
Further company coverage: ARBN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma USA Receives FTC Approval To Acquire Lannett Company
Brief: Aurobindo Pharma Obtains US FTC Approval For Lannett Acquisition
FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett (updated)
FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett Company Inc.
HSBC sees no earnings hit from FDA action on India's Aurobindo Pharma